151 related articles for article (PubMed ID: 24011804)
1. The host immune response contributes to Haemophilus influenzae virulence.
Geelen TH; Gaajetaan GR; Wouters EF; Rohde GG; Franssen FM; Grauls GE; Stobberingh EE; Bruggeman CA; Stassen FR
Respir Med; 2014 Jan; 108(1):144-52. PubMed ID: 24011804
[TBL] [Abstract][Full Text] [Related]
2. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease.
Alikhan MM; Lee FE
Curr Opin Pulm Med; 2014 Mar; 20(2):159-64. PubMed ID: 24441573
[TBL] [Abstract][Full Text] [Related]
3. Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.
King PT; Lim S; Pick A; Ngui J; Prodanovic Z; Downey W; Choong C; Kelman A; Baranyai E; Francis M; Moshinsky R; Bardin PG; Holmes PW; Holdsworth SR
J Allergy Clin Immunol; 2013 May; 131(5):1314-21.e14. PubMed ID: 23142009
[TBL] [Abstract][Full Text] [Related]
4. Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD.
Staples KJ; Taylor S; Thomas S; Leung S; Cox K; Pascal TG; Ostridge K; Welch L; Tuck AC; Clarke SC; Gorringe A; Wilkinson TM
PLoS One; 2016; 11(11):e0167250. PubMed ID: 27898728
[TBL] [Abstract][Full Text] [Related]
5. Diesel exhaust alters the response of cultured primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD) to non-typeable Haemophilus influenzae.
Zarcone MC; van Schadewijk A; Duistermaat E; Hiemstra PS; Kooter IM
Respir Res; 2017 Jan; 18(1):27. PubMed ID: 28129777
[TBL] [Abstract][Full Text] [Related]
6. The adhesins of non-typeable Haemophilus influenzae.
Osman KL; Jefferies JM; Woelk CH; Cleary DW; Clarke SC
Expert Rev Anti Infect Ther; 2018 Mar; 16(3):187-196. PubMed ID: 29415569
[TBL] [Abstract][Full Text] [Related]
7. Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients.
Baffetta F; Buonsanti C; Moraschini L; Aprea S; Canè M; Lombardi S; Contorni M; Rondini S; Arora AK; Bardelli M; Finco O; Serruto D; Paccani SR
Hum Vaccin Immunother; 2024 Dec; 20(1):2343544. PubMed ID: 38655676
[TBL] [Abstract][Full Text] [Related]
8. Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations.
Berenson CS; Kruzel RL; Eberhardt E; Dolnick R; Minderman H; Wallace PK; Sethi S
Thorax; 2014 Sep; 69(9):811-8. PubMed ID: 24686454
[TBL] [Abstract][Full Text] [Related]
9. Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.
Ahearn CP; Gallo MC; Murphy TF
Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28449098
[TBL] [Abstract][Full Text] [Related]
10. Role of nontypeable Haemophilus influenzae in otitis media and chronic obstructive pulmonary disease.
Thanavala Y; Lugade AA
Adv Otorhinolaryngol; 2011; 72():170-5. PubMed ID: 21865721
[TBL] [Abstract][Full Text] [Related]
11. The Pulmonary Extracellular Matrix Is a Bactericidal Barrier Against
Abdillahi SM; Tati R; Nordin SL; Baumgarten M; Hallgren O; Bjermer L; Erjefält J; Westergren-Thorsson G; Singh B; Riesbeck K; Mörgelin M
Front Immunol; 2018; 9():1988. PubMed ID: 30233584
[TBL] [Abstract][Full Text] [Related]
12. Haemophilus influenzae and smoking-related obstructive airways disease.
Otczyk DC; Clancy RL; Cripps AW
Int J Chron Obstruct Pulmon Dis; 2011; 6():345-51. PubMed ID: 21760721
[TBL] [Abstract][Full Text] [Related]
13. Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers.
Chin CL; Manzel LJ; Lehman EE; Humlicek AL; Shi L; Starner TD; Denning GM; Murphy TF; Sethi S; Look DC
Am J Respir Crit Care Med; 2005 Jul; 172(1):85-91. PubMed ID: 15805181
[TBL] [Abstract][Full Text] [Related]
14. Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection.
Hinks TS; Wallington JC; Williams AP; Djukanović R; Staples KJ; Wilkinson TM
Am J Respir Crit Care Med; 2016 Nov; 194(10):1208-1218. PubMed ID: 27115408
[TBL] [Abstract][Full Text] [Related]
15. Haemophilus influenzae: recent advances in the understanding of molecular pathogenesis and polymicrobial infections.
Jalalvand F; Riesbeck K
Curr Opin Infect Dis; 2014 Jun; 27(3):268-74. PubMed ID: 24699388
[TBL] [Abstract][Full Text] [Related]
16. Dectin-1 is expressed in human lung and mediates the proinflammatory immune response to nontypeable Haemophilus influenzae.
Heyl KA; Klassert TE; Heinrich A; Müller MM; Klaile E; Dienemann H; Grünewald C; Bals R; Singer BB; Slevogt H
mBio; 2014 Aug; 5(5):e01492-14. PubMed ID: 25161190
[TBL] [Abstract][Full Text] [Related]
17. Calcium restores the macrophage response to nontypeable haemophilus influenzae in chronic obstructive pulmonary disease.
Provost KA; Smith M; Arold SP; Hava DL; Sethi S
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):728-37. PubMed ID: 25338285
[TBL] [Abstract][Full Text] [Related]
18. IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Roos AB; Sethi S; Nikota J; Wrona CT; Dorrington MG; Sandén C; Bauer CM; Shen P; Bowdish D; Stevenson CS; Erjefält JS; Stampfli MR
Am J Respir Crit Care Med; 2015 Aug; 192(4):428-37. PubMed ID: 26039632
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease.
Sharan R; Perez-Cruz M; Kervoaze G; Gosset P; Weynants V; Godfroid F; Hermand P; Trottein F; Pichavant M; Gosset P
Mucosal Immunol; 2017 Jan; 10(1):139-149. PubMed ID: 27143304
[TBL] [Abstract][Full Text] [Related]
20. Multi-site placebo-controlled randomised clinical trial to assess protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.
Clancy RL; Dunkley ML; Sockler J; McDonald CF
Intern Med J; 2016 Jun; 46(6):684-93. PubMed ID: 27009822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
